Evotec (NASDAQ:EVO) Shares Gap Up – Still a Buy?

Evotec SE (NASDAQ:EVO) gapped up before the market opened on Friday . The stock had previously closed at $3.91, but opened at $4.16. Evotec shares last traded at $4.34, with a volume of 39,868 shares trading hands.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft raised Evotec from a “sell” rating to a “hold” rating in a report on Thursday, April 24th.

Evotec Trading Up 10.7 %

The company’s fifty day simple moving average is $3.61 and its 200-day simple moving average is $4.16. The company has a current ratio of 2.09, a quick ratio of 1.99 and a debt-to-equity ratio of 0.43.

Institutional Investors Weigh In On Evotec

Several large investors have recently bought and sold shares of EVO. DCF Advisers LLC raised its position in shares of Evotec by 227.0% in the first quarter. DCF Advisers LLC now owns 751,579 shares of the company’s stock valued at $2,510,000 after buying an additional 521,708 shares during the last quarter. ABC Arbitrage SA acquired a new position in Evotec in the first quarter valued at approximately $260,000. Lighthouse Investment Partners LLC purchased a new position in shares of Evotec during the 4th quarter worth $166,000. CSS LLC IL purchased a new stake in shares of Evotec in the 4th quarter valued at approximately $50,000. Finally, Bank of America Corp DE lifted its stake in Evotec by 262.5% during the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock worth $53,000 after purchasing an additional 9,289 shares in the last quarter. 5.81% of the stock is currently owned by hedge funds and other institutional investors.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.